Net Income

Defiance just launched an ETF to short the newly public SpaceX. We dive into the high-stakes gamble on a trillion-dollar titan and the perilous tools of modern trading.

A silent productivity drain is costing businesses dearly. Over half the workforce aged 40-60 is managing elder care, and the financial and career toll is immense.

Calgary's Douglas Vermeeren faces new fraud charges despite a 10-year ban. His case reveals a high-stakes battle between regulators and persistent predators.

The electric boat innovator executes another reverse stock split to stay on Nasdaq, but a history of similar moves raises questions about its financial health.

New clinical trial results for XWRAP® show a significant leap in healing diabetic ulcers, positioning Applied Biologics as a formidable player in a challenging field.

With projections of $22.7M from four new supplements, Cosmos Health is betting big on the US. But can its 'science-driven' platform deliver in a crowded market?

Facing a 'going concern' warning and collapsing revenue, Splash Beverage Group is ditching drinks for drugs. Its investment in Avicanna is a desperate, yet strategic, pivot.

Seadrill's move to replace secured debt with unsecured notes is more than a balance sheet tweak; it’s a strategic signal of renewed market confidence.

As nurses and for-profit homes enter bitter arbitration, the standoff exposes a critical flaw in long-term care: a business model at odds with its mission.

Horizon Petroleum finalizes its Polish gas acquisition with a shrewd, all-cash deal, betting on long-term profits to fuel Poland's energy independence.

A small Canadian firm's breakthrough in water technology could slash energy use in major industries. But can it overcome the hurdles to commercialization?

After 990 tense sessions and a recent strike, Colombia's energy giant secured a landmark 6-year labor deal. A look at the numbers reveals a strategic trade-off.

Amid widening losses and a squeezed consumer, the children's retailer is monetizing assets and cutting deep into its supply chain. A new team bets on it being enough.

A landmark deal for CEL-SCI’s cancer drug Multikine in Saudi Arabia isn't just about a new market; it’s a case study in national ambition and biotech finance.

Celebrating 50 years, the largest US ethnic credit union awarded a record $700K to 602 students, reinforcing its deep commitment to the Polish-American community.

As Jones Soda prepares for the Planet MicroCap conference, its impressive financial rebound and bold diversification strategy take center stage for investors.

As SpaceX makes its historic market debut, GraniteShares launches leveraged ETFs, offering traders a high-stakes way to bet on the volatile space pioneer.

While firms spend billions on tech, a new book argues the biggest data breaches stem from leadership gaps and process failures. Is your boardroom the real front line?

FCPT's latest acquisition seems minor, but it reveals a powerful strategy for navigating economic uncertainty by targeting essential, service-based real estate.

Tokyo-based CTW, a leader in web-based anime games, is pitching to US microcap funds. What's the strategy behind this cross-border play for capital?